• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAINSTAY MEDICAL LIMITED REACTIVI8; REACTIV8 PERCUTANEOUS STIMULATION LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAINSTAY MEDICAL LIMITED REACTIVI8; REACTIV8 PERCUTANEOUS STIMULATION LEAD Back to Search Results
Model Number 8145
Device Problem Failure to Conduct (1114)
Patient Problem Failure of Implant (1924)
Event Date 01/04/2023
Event Type  malfunction  
Event Description
It was reported that the patient was unable to activate stimulation.The patient stated that her back pain had been adversely impacted.The field clinical engineer (fce) verified that the right lead had progressive loss of electrodes due to out-of-range.The fce reprogrammed the device to use unilateral therapy only to cover the period until revision surgery can be scheduled.There was no report of patient harm or injury due to the event.The patient underwent revision surgery on (b)(6) 2023, to remove and replace the right percutaneous stimulation lead.The lead assembly was returned and evaluated.The reported issue was verified.Analysis confirmed lead conductor fractures were the cause of the out-of-range impedance conditions observed with the right percutaneous stimulation lead.
 
Manufacturer Narrative
Mml reference # (b)(4).
 
Manufacturer Narrative
Mml reference #(b)(4).Corrected b4: date of submission of this report from 1/4/2023 to 02/03/2023.
 
Event Description
It was reported that the patient was unable to activate stimulation.The patient stated that her back pain had been adversely impacted.The field clinical engineer (fce) verified that the right lead had progressive loss of electrodes due to out-of-range.The fce reprogrammed the device to use unilateral therapy only to cover the period until revision surgery can be scheduled.There was no report of patient harm or injury due to the event.The patient underwent revision surgery on (b)(6) 2023, to remove and replace the right percutaneous stimulation lead.The lead assembly was returned and evaluated.The reported issue was verified.Analysis confirmed lead conductor fractures were the cause of the out-of-range impedance conditions observed with the right percutaneous stimulation lead.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REACTIVI8
Type of Device
REACTIV8 PERCUTANEOUS STIMULATION LEAD
Manufacturer (Section D)
MAINSTAY MEDICAL LIMITED
clonmel house, forster way
swords, county dublin K67F2
EI  K67F2
Manufacturer Contact
liza dominguez
6601 shingle creek parkway
suite 200
brooklyn center, MN 55430
6192063331
MDR Report Key16293875
MDR Text Key308854321
Report Number3013017877-2023-00001
Device Sequence Number1
Product Code QLK
UDI-Device Identifier05391527772064
UDI-Public(01)05391527772064
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P190021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 02/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model Number8145
Device Catalogue Number8145
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/16/2023
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 01/04/2023
Initial Date FDA Received02/03/2023
Supplement Dates Manufacturer Received01/04/2023
Supplement Dates FDA Received02/03/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/23/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-